Molecular Oncology
Volume 2, Issue 2 , Pages 115-152 , August 2008

Imaging and cancer: A review

  • Leonard Fass

      Affiliations

    • GE Healthcare, 352 Buckingham Avenue, Slough, SL1 4ER, UK
    • Imperial College Department of Bioengineering, London, UK
    • Corresponding Author InformationCorresponding author. Tel.: +44 7831 117132; fax: +44 1753 874578.

Received 6 March 2008 ,Revised 28 April 2008 ,Accepted 29 April 2008.

References 

  1. Aberg P, Nicander I, Hansson J, Geladi P, Holmgren U, Ollmar S. Skin cancer identification using multifrequency electrical impedance – a potential screening tool. IEEE Transactions on Biomedical Engineering. 2004;51:2097–2102
  2. Aboagye EO, Bhujwalla ZM. Malignant transformation alters membrane choline phospholipid metabolism of human mammary epithelial cells. Cancer Research. 1999;59:80–84
  3. Aboagye EO, Bhujwalla ZM, Shungu DC, Glickson JD. Detection of tumour response to chemotherapy by 1H nuclear magnetic resonance spectroscopy: effect of 5-fluorouracil on lactate levels in radiation-induced fibrosarcoma I tumours. Cancer Research. 1998;58:1063–1067
  4. Abourbeh G, Dissoki S, Jacobson O, et al. Evaluation of radiolabeled ML04, a putative irreversible inhibitor of epidermal growth factor receptor, as a bioprobe for PET imaging of EGFR-overexpressing tumors. Nuclear Medicine and Biology. 2007;34:55–70
  5. Albertoni P. Novel antitenascin antibody with increased tumour localisation for pretargeted antibody-guided radioimmunotherapy (PAGRIT). British Journal of Cancer. 2003;88:996–1003
  6. American College of Radiology . Breast Imaging Reporting and Data System (BI-RADS). fourth ed.. Reston, VA: American College of Radiology; 2004;
  7. Anderson HL, Yap JT, Miller MP, et al. Assessment of pharmacodynamic vascular response in a phase I trial of combretastatin A4 phosphate. Journal of Clinical Oncology. 2003;21:2823–2830
  8. Anwer K, et al. Ultrasound enhancement of cationic lipid mediated gene transfer to primary tumors following systemic administration. Gene Therapy. 2000;7:1833–1839
  9. Ardenkjaer-Larsen JH, et al. Increase in signal-to noise ratio of >10,000 times in liquid-state NMR. Proceedings of the National Academy of Sciences USA. 2003;100:10158–10163
  10. Artemov D, Mori N, Okollie B, Bhujwalla ZM. MR molecular imaging of the Her-2/neu receptor in breast cancer cells using targeted iron oxide nanoparticles. Magnetic Resonance in Medicine. 2003;49:403–408
  11. Ashamalla H, Rafla S, Parikh K, Mokhtar B, Goswami G, Kambam S, et al. The contribution of integrated PET/CT to the evolving definition of treatment volumes in radiation treatment planning in lung cancer. International Journal of Radiation Oncology Biology Physics. 2005;63:1016–1023
  12. Atri M. New technologies and directed agents for applications of cancer imaging. Journal of Clinical Oncology. 2006;24(20):3299–3308
  13. Backer MV, et al. Molecular imaging of VEGF receptors in angiogenic vasculature with single-chain VEGF-based probes. Nature Medicine. 2007;13:504–509
  14. Bae U, et al. Ultrasound thyroid elastography using carotid artery pulsation. Journal of Ultrasound in Medicine. 2007;26:797–805
  15. Balamugesh T, et al. Empyema – a rare complication of transbronchial lung biopsy. Respiratory Medicine Extra. 2005;1(3):97–99
  16. Bartella L, Huang W. Proton (1H) MR spectroscopy of the breast. RadioGraphics. 2007;27:S241–S252
  17. Bartella L, et al. Enhancing non-mass lesions in the breast: evaluation with proton (1H) MR spectroscopy. Radiology. 2007;245:80–87
  18. Barthel H, et al. 3′-Deoxy-3′-[18F]fluorothymidine as a new marker for monitoring tumor response to antiproliferative therapy in vivo with positron emission tomography. Cancer Research. 2003;63:3791–3798
  19. Bauer W, Claudia C, Langer O. Microdosing studies in humans: the role of positron emission tomography. Drugs in R & D. 2008;9(2):73–81
  20. Bayford RH. Bioimpedance tomography (electrical impedance tomography). Annual Review of Biomedical Engineering. 2006;8:63–91
  21. Beck R, et al. Pretreatment 18F-FAZA predicts success of hypoxia directed radiochemotherapy using tirapazamine. Journal of Nuclear Medicine. 2007;48(6):973–980
  22. Beer AJ, Haubner R, Wolf I, et al. PET-based human dosimetry of 18Fgalacto- RGD, a new radiotracer for imaging alpha v beta3 expression. Journal of Nuclear Medicine. 2006;47:763–769
  23. Beheshti M, et al. [18F]Fluorocholine PET/CT in the assessment of bone metastases in prostate cancer. European Journal of Nuclear Medicine and Molecular Imaging. 2007;34(8):1316–1317
  24. Belfiore G, Tedeschi E, Moggio G, Coffi R, Cincotti FC, Rossi R. CT-guided radiofrequency palliative ablation of unresectable lung cancer: clinical and imaging findings at one-year follow-up. Radiology. 2004;233:513;abstract SSK05-06
  25. Belhocine TZ, et al. Role of nuclear medicine in the management of cutaneous malignant melanoma. Journal of Nuclear Medicine. 2006;47:957–967
  26. Bergers G, Song S. The role of pericytes in blood-vessel formation and maintenance. Neuro-Oncology. 2005;7(4):452–464
  27. Bergland A, et al. Metaiodobenzylguanidine (MIBG) scintigraphy and computed tomography (CT) in clinical practice. Primary and secondary evaluation for localization of phaeochromocytomas. Journal of Internal Medicine. 2001;249(3):247–251
  28. Bergstrom M, Grahnen A, Langstrom B. Positron emission tomography microdosing: A new concept with application in tracer and early clinical drug development. European Journal of Clinical Pharmacology. 2003;59:357–366
  29. Bertino JS, Greenberg HE, Reed MD. American College of Clinical Pharmacology Position Statement on the Use of Microdosing in the Drug Development Process. Journal of Clinical Pharmacology. 2007;47(4):418–422
  30. Beyer T, Townsend DW, Blodgett TM. Dual-modality PET/CT tomography for clinical oncology. Quarterly Journal of Nuclear Medicine. 2002;46:24–34
  31. Bhattacharyya M, et al. Using MRI to plan breast-conserving surgery following neoadjuvant chemotherapy for early breast cancer. British Journal of Cancer. 2008;98:289–293
  32. Blana A, Walter B, Rogenhofer S, Wieland WF. High-intensity focused ultrasound for the treatment of localized prostate cancer: 5-year experience. Urology. 2004;63:297–300
  33. Boddy AV, et al. Pharmacokinetic investigation of imatinib using accelerator mass spectrometry in patients with chronic myeloid leukemia. Clinical Cancer Research. 2007;13:4164–4169
  34. Bohndiek SE, et al. A CMOS active pixel sensor system for laboratory-based x-ray diffraction studies of biological tissue. Physics in Medicine and Biology. 2008;53:655–672
  35. Bolster JM, Vaalburg W, Paans AM, et al. Carbon-11 labelled tyrosine to study tumor metabolism by positron emission tomography (PET). European Journal of Nuclear Medicine. 1986;12:321–324
  36. Brasch R, Turetschek K. MRI characterization of tumors and grading angiogenesis using macromolecular contrast media: status report. European Journal of Radiology. 2000;34:148–155
  37. Brem RF, Rapelyea JA, Zisman G, et al. Occult breast cancer: scintimammography with high-resolution breast-specific gamma camera in women at high risk for breast cancer. Radiology. 2005;237(1):274–280
  38. Brem RF, et al. Breast-specific gamma imaging with 99mTc-sestamibi and magnetic resonance imaging in the diagnosis of breast cancer: a comparative study. Breast Journal. 2007;13(5):465–469
  39. Brenner DJ, Elliston CD, Hall EJ, et al. Estimating cancer risks from pediatric CT: going from the qualitative to the quantitative. Pediatric Radiology. 2002;32:228–231
  40. Brindle KM. Molecular imaging using magnetic resonance: new tools for the development of tumour therapy. British Journal of Radiology. 2003;76:S111–S117
  41. Brindle K. New approaches for imaging tumour responses to treatment. Nature Reviews Cancer. 2008;8:94–107
  42. Brink I, Schumacher T, Mix M, et al. Impact of [18F]FDG-PET on the primary staging of small-cell lung cancer. European Journal of Nuclear Medicine and Molecular Imaging. 2004;31:1614–1620
  43. Brix G, Lechel U, Glatting G. Radiation exposure of patients undergoing whole-body dual-modality 18F-FDG PET/CT examinations. Journal of Nuclear Medicine. 2005;46:608–613
  44. Buadu LD, et al. Breast lesions: correlation of contrast medium enhancement patterns on MR images with histopathologic findings and tumor angiogenesis. Radiology. 1996;200:639–649
  45. Buckley DL, et al. Microvessel density of invasive breast cancer assessed by dynamic Gd-DTPA enhanced MRI. Journal of Magnetic Resonance Imaging. 1997;7:461–464
  46. Buijs M, et al. Assessment of metastatic breast cancer response to chemoembolization with contrast agent enhanced and diffusion-weighted MR imaging. Journal of Vascular and Interventional Radiology. 2007;18(8):957–963
  47. Burnside E, et al. Differentiating benign from malignant solid breast masses with US strain imaging. Radiology. 2007;245(2):401–410
  48. Buzug TM, et al. MRI based attenuation correction for brain PET images. Advances in Medical Imaging. 2007;114:93–97
  49. Byrne A, Nadel H. Whole body low dose 18F-FDG PET/CT in pediatric oncology. Journal of Nuclear Medicine. 2007;48(suppl. 2):118;abstract
  50. Cai W, et al. PET of vascular endothelial growth factor receptor expression. Journal of Nuclear Medicine. 2006;47:2048–2056
  51. Campadelli P, Casiraghi I, Artioli DA. Fully automated method for lung nodule detection from postero-anterior chest radiographs. Medical Imaging. 2006;25(12):1588–1603
  52. Carrino JA, Jolesz FA. MRI-guided interventions. Academic Radiology. 2005;12:1063–1064
  53. Cascini GL, et al. 18F-FDG PET is an early predictor of pathologic tumor response to preoperative radiochemotherapy in locally advanced rectal cancer. Journal of Nuclear Medicine. 2006;47(8):1241–1248
  54. Catane R, et al. MR-guided focused ultrasound surgery (MRgFUS) for the palliation of pain in patients with bone metastases – preliminary clinical experience. Annals of Oncology. 2007;18:163–167
  55. Chan WC, Maxwell DJ, Gao X, Bailey RE, Han M, Nie S. Luminescent quantum dots for multiplexed biological detection and imaging Current Opinion in Biotechnology. 2002;13:40–46
  56. Chen W, et al. Imaging proliferation in brain tumors with 18F-FLT PET: comparison with 18F-FDG. Journal of Nuclear Medicine. 2005;46(6):945–952
  57. Chen X, et al. MicroPET imaging of brain tumor angiogenesis with 18F labeled PEGylated RGD peptide. European Journal of Nuclear Medicine and Molecular Imaging. 2004;31(8):1081–1089
  58. Chen X, et al. MicroPET imaging of breast cancer alpha(v)-integrin expression with 64Cu-labeled dimeric RGD peptides. Molecular Imaging and Biology. 2004;6(5):350–359
  59. Chen X, et al. Pharmacokinetics and tumor retention of (125)I-labeled RGD peptide are improved by PEGylation. Nuclear Medicine and Biology. 2004;31(1):11–19
  60. Chen X, Plasencia C, Hou Y, et al. Synthesis and biological evaluation of dimeric RGD peptide-paclitaxel conjugate as a model for integrin-targeted drug delivery. Journal of Medicinal Chemistry. 2005;48:1098–1106
  61. Chenevert TL, Stegman LD, Taylor JMG, Robertson PL, Greenberg HS, Rehemtulla A, et al. Diffusion magnetic resonance imaging: an early surrogate marker of therapeutic efficacy in brain tumors. Journal of the National Cancer Institute. 2000;92:2029–2036
  62. Cherepenin V, et al. A 3D electrical impedance tomography (EIT) system for breast cancer detection. Physiological Measurement. 2001;22:9–18
  63. Ciernik IF, Dizendorf E, Baumert BG, Reiner B, Burger C, Davis JB, et al. Radiation treatment planning with an integrated positron emission and computer tomography (PET/CT): a feasibility study. International Journal of Radiation Oncology Biology Physics. 2003;57:853–863
  64. Civelek AC, et al. Tc-99m sestamibi uptake in the chest mimicking a malignant lesion of the breast. The Breast. 2006;15(1):111–114
  65. Cohen A, et al. Monitoring of chemotherapy induced cell death in melanoma tumors by N,N′-didansyl-l-cystine. Technology in Cancer Research & Treatment. 2007;6(3):221–234
  66. Coover LR, Caravaglia G, Kunh P, et al. Scintimammography with dedicated breast camera detects and localizes occult carcinoma. Journal of Nuclear Medicine. 2004;45(4):553–558
  67. Czernin J, Weber WA, Herschman HR. Molecular imaging in the development of cancer therapeutics. Annual Reviews of Medicine. 2006;57:99–118
  68. Damadian R. Tumor detection by nuclear magnetic resonance. Science. 1971;171:1151–1153
  69. Day SE, et al. Detecting tumor response to treatment using hyperpolarized 13C magnetic resonance imaging and spectroscopy. Nature Medicine. 2007;13:1382–1387
  70. De Boer RJ, et al. Carbon-11 tyrosine PET for visualization and protein synthesis rate assessment of laryngeal and hypopharyngeal carcinomas. European Journal of Nuclear Medicine. 2002;29:1182–1187
  71. de Geus-Oei L-F, et al. Chemotherapy response evaluation with 18F-FDG PET in patients with non-small cell lung cancer. Journal of Nuclear Medicine. 2007;48(10):1592–1598
  72. de Geus-Oei LF, et al. Chemotherapy response evaluation with FDG-PET in patients with colorectal cancer. Annals of Oncology. 2008;19(2):348–352
  73. de Torres JP, et al. Assessing the relationship between lung cancer risk and emphysema detected on low-dose CT of the chest. Chest. 2007;132:1932–1938
  74. Dehdashti F, et al. Positron tomographic assessment of estrogen receptors in breast cancer: comparison with FDG-PET and in vitro receptor assays. Journal of Nuclear Medicine. 1995;36(10):1766–1772
  75. Dehdashti F, et al. Positron tomographic assessment of androgen receptors in prostatic carcinoma. European Journal of Nuclear Medicine and Molecular Imaging. 2005;32(3):344–350
  76. Dehghani H, Pogue PW, Poplack SP, Paulsen KD. Multiwavelength three-dimensional near-infrared tomography of the breast: initial simulation, phantom, and clinical results. Applied Optics. 2003;42:135–145
  77. Dekker B, Keen H, Lyons S, et al. MBP-annexin V radiolabeled directly with iodine-124 can be used to image apoptosis in vivo using PET. Nuclear Medicine and Biology. 2005;32:241–252
  78. D'Hallewin MA, El Khatib S, Leroux A, Bezdetnaya L, Guillemin F. Endoscopic confocal fluorescence microscopy of normal and tumor bearing rat bladder. Journal of Urology. 2005;174(2):736–740
  79. Diekmann F, Bick U. Tomosynthesis and contrast-enhanced digital mammography; recent advances in digital mammography. European Radiology. 2007;17(12):3086–3092
  80. Dobbins JT, et al. Digital x-ray tomosynthesis: current state of the art and clinical potential. Physics in Medicine and Biology. 2003;48:R65–R106
  81. Downey RJ, Akhurst T, Ilson D, et al. Whole body18-F FDG-PET and the response of esophageal cancer to induction therapy: results of a prospective trial. Journal of Clinical Oncology. 2003;21:428–432
  82. Downey RJ, Akhurst T, Gonen M, et al. Preoperative F-18 fluorodeoxyglucose-positron emission tomography maximal standardized uptake value predicts survival after lung cancer resection. Journal of Clinical Oncology. 2004;22:3255–3260
  83. Dromi S, et al. Pulsed-high intensity focused ultrasound and low temperature-sensitive liposomes for enhanced targeted drug delivery and anti-tumor effect. Clinical Cancer Research. 2007;13(9):2722–2727
  84. Dugdale PE, Miles KA, Bunce I, Kelley BB, Leggett DAC. CT measurement of perfusion and permeability within lymphoma masses and its ability to assess grade, activity, and chemotherapeutic response. Journal of Computer Assisted Tomography. 1999;23(4):540–547
  85. Ehman RL, et al. Blueprint for imaging in biomedical research. Radiology. 2007;244(1):12
  86. Enquobahrie AA, et al. Automated detection of small pulmonary nodules in whole lung CT scans. Academic Radiology. 2007;14(5):579–593
  87. Eriksson B, et al. The role of PET in localization of neuroendocrine and adrenocortical tumors. Annals of the New York Academy of Sciences. 2002;970:159–169
  88. Eschmann SM, Paulsen F, Reimold M, et al. Prognostic impact of hypoxia imaging with 18F-misonidazole PET in non-small cell lung cancer and head and neck cancer before radiotherapy. Journal of Nuclear Medicine. 2005;46:253–260
  89. European Agency for the Evaluation of Medicinal Products . Evaluation of Medicines for Human Use. Position Paper on Non-Clinical Safety Studies to Support Clinical Trials with a Single Microdose. London: EMEA; 2003;pp. 1-4
  90. Evans SF, et al. 18F EF5 PET imaging with immunohistochemical validation in patients with brain lesions. International Journal of Radiation Oncology Biology Physics. 2006;66(3):S248
  91. Even-Sapir E, et al. Lymphoscintigraphy for sentinel node mapping using a hybrid SPECT/CT system. Journal of Nuclear Medicine. 2003;44(9):1413–1420
  92. Fahey BJ, et al. Liver ablation guidance with acoustic radiation force impulse imaging: challenges and opportunities. Physics in Medicine and Biology. 2006;51:3785–3808
  93. Fahey BJ, et al. In vivo visualization of abdominal malignancies with acoustic radiation force elastography. Physics in Medicine and Biology. 2008;53:279–293
  94. Fani M, et al. Comparative evaluation of linear and cyclic 99mTc-RGD peptides for targeting of integrins in tumor angiogenesis. AntiCancer Research. 2006;26(1A):431–434
  95. Fermé C, et al. Role of imaging to choose treatment. Cancer Imaging. 2005;5:S113–S119
  96. Fogelman I, et al. Positron emission tomography and bone metastases. Seminars in Nuclear Medicine. 2005;35(2):135–142
  97. Folkman J. The role of angiogenesis in tumor growth. Seminars in Cancer Biology. 1992;3:65–71
  98. Fournier L, et al. Dynamic contrast-enhanced CT (DCE-CT) as an early biomarker of response in metastatic renal cell carcinoma (mRCC) under anti-angiogenic treatment. 2007 ASCO Annual Meeting Proceedings Part I Journal of Clinical Oncology. 2007;25(18S):(abstract 14003)
  99. Franceschini MA, et al. Frequency-domain techniques enhance optical mammography: initial clinical results. Proceedings of the National Academy of Sciences USA. 1997;94:6468–6473
  100. Frank R, Hargreaves R. Clinical biomarkers in drug discovery and development. Nature Reviews Drug Discovery. 2003;2(7):566–580
  101. Front D, et al. Aggressive non-Hodgkin lymphoma: early prediction of outcome with 67Ga scintigraphy. Radiology. 2000;214:253–257
  102. Frush DP, Donnelly LF, Rosen NS. Computed tomography and radiation risks: what pediatric health care providers should know. Pediatrics. 2003;112:951–957
  103. Furtado CD, et al. Whole body CT screening: spectrum of findings and recommendations in 1192 patients. Radiology. 2005;237(2):385–394
  104. Furusawa H, Namba K, Thomasen S, Akiyama F, Bendet A, Tanaka C, et al. Magnetic resonance-guided focused ultrasound surgery of breast cancer: reliability and effectiveness. Journal of the American College of Surgeons. 2006;203(1):54–63
  105. Gangi A, et al. Injection of alcohol into bone metastases under CT guidance. Journal of Computer Assisted Tomography. 1994;18:932–935
  106. Gao X, Yang L, Petros JA, et al. In vivo molecular and cellular imaging with quantum dots. Current Opinion in Biotechnology. 2005;16:63–72
  107. Gao Z, et al. Drug-loaded nano/microbubbles for combining ultrasonography and targeted chemotherapy. Ultrasonics, in press.
  108. GE Senographe, 1999. 2000D FDA PMA submission P990066.
  109. Geddes LA, Baker LE. The specific resistance of biological materials: a compendium of data for the biomedical engineer and physiologist. Medical and Biological Engineering. 1967;5:271–293
  110. Getty D, et al. 2007. Improved accuracy of lesion detection in breast cancer screening with stereoscopic digital mammography. RSNA Meeting 2007 (abstract SSG01–04).
  111. Ghandi S, et al. Lipiodol-guided computed tomography for radiofrequency ablation of hepatocellular carcinoma. Clinical Radiology. 2006;61(10):888–891
  112. Gianfelice D, Khiat A, Boulanger Y, et al. Feasibility of magnetic resonance imaging-guided focused ultrasound surgery as an adjunct to tamoxifen therapy in high-risk surgical patients with breast carcinoma. Journal of Vascular and Interventional Radiology. 2003;14:1275–1282
  113. Gilkeson RC, Sachs PB. Dual energy subtraction digital radiography: technical considerations, clinical applications, and imaging pitfalls. classic concepts in thoracic imaging. Journal of Thoracic Imaging. 2006;21(4):303–313
  114. Gillies RJ, Morse DL. In vivo magnetic resonance spectroscopy in cancer. Annual Review of Biomedical Bioengineering. 2005;7:287–326
  115. Gillies JM, et al. Microfluidic technology for PET radiochemistry. Applied Radiation and Isotopes. 2006;64(3):333–336
  116. Ginos JZ, Cooper AJ, Dhawan V, et al. [13N]Cisplatin PET to assess pharmacokinetics of intra-arterial versus intravenous chemotherapy for malignant brain tumors. Journal of Nuclear Medicine. 1987;28:1844–1852
  117. Goel M, et al., 2006. Application of near infrared multi-spectral CCD imager system to determine the hemodynamic changes in prostate tumor. OSA Biomedical Topical Meetings: SH10, Fort Lauderdale, FL.
  118. Golman K, Petersson JS. Metabolic imaging and other applications of hyperpolarized 13C. Academic Radiology. 2006;13:932–942
  119. Golman K, Zandt RI, Lerche M, Pehrson R, Ardenkjaer-Larsen JH. Metabolic imaging by hyperpolarized 13C magnetic resonance imaging for in vivo tumor diagnosis. Cancer Research. 2006;66:10855–10860
  120. Golman K, Zandt RI, Thaning M. Real-time metabolic imaging. Proceedings of the National Academy of Sciences USA. 2006;103:11270–11275
  121. Grazioso R, et al. APD-based PET detector for simultaneous PET/MR imaging. Nuclear Instruments and Methods in Physics Research Section A: Accelerators, Spectrometers. Detectors and Associated Equipment. 2006;569(2):301–305
  122. Gromet M. Comparison of computer-aided detection to double reading of screening mammograms: review of 231,221 mammograms. AJR American Journal of Roentgenology. 2008;190(4):854–859
  123. Grönroos T, et al. Comparison of the biodistribution of two hypoxia markers[18F]FETNIM and [18F]FMISO in an experimental mammary carcinoma. European Journal of Nuclear Medicine and Molecular Imaging. 2004;31(4):513–520
  124. Grosenick D, et al. Development of a time domain optical mammograph and first in vivo applications. Applied Optics. 1999;38:2927–2943
  125. Grosu A, et al. Hypoxia imaging with 18F-FAZA-PET for dose painting using intensity modulated radiotherapy in patients with head and neck cancer. International Journal of Radiation Oncology Biology Physics. 2005;63(Suppl 1):S132–S133
  126. Gu X, et al. Differentiation of cysts from solid tumors in the breast with diffuse optical tomography. Academic Radiology. 2004;11(1):2094–2107
  127. Gupta N, Price PM, Aboagye EO. PET for in vivo pharmacokinetic and pharmacodynamic measurements. European Journal of Cancer. 2002;38:2094–2107
  128. Gusev VE, Karabutov AA. Laser Optoacoustics. American Institute of Physics; 1993;
  129. Haider MA, et al. Combined T2-weighted and diffusion-weighted MRI for localization of prostate cancer. AJR American Journal of Roentgenology. 2000;189:323–328
  130. Hainfeld JF, Slatkin DN, Focella TM, Smilowitz HM. Gold nanoparticles: a new X-ray contrast agent. British Journal of Radiology. 2006;79:248–253
  131. Halter R, Hatrov A, Paulsen KD. High frequency EIT for breast imaging. Sixth Conference on Biomedical Application of Electrical Impedance Tomography, London, UK (2005).
  132. Halter RJ, Hartov A, Paulsen KD. A broadband high-frequency electrical impedance tomography system for breast imaging. IEEE Transactions on Biomedical Engineering. 2008;55(2):650–659
  133. Harishingani MG, et al. Noninvasive detection of clinically occult lymph-node metastases in prostate cancer. New England Journal of Medicine. 2003;348:2491–2499
  134. Hayashi K, et al. Local therapeutic results of computed tomography-guided transcatheter arterial chemoembolization for hepatocellular carcinoma: results of 265 tumors in 79 patients. Cardiovascular and Interventional Radiology. 2007;30:1144–1155
  135. He W, Wang HF, Hartmann LC, Cheng JX, Low PS. In vivo quantitation of rare circulating tumor cells by multiphoton intravital flow cytometry. Proceedings of the National Academy of Sciences USA. 2007;104:11760–11765
  136. Hehenberger M, et al. IT solutions for imaging biomarkers in biopharmaceutical research and development. Information-Based Medicine. 2007;46(1):183–198
  137. Heilbrun ME, et al. CT-guided biopsy for the diagnosis of renal tumors before treatment with percutaneous ablation. AJR American Journal of Roentgenology. 2007;188(6):1500–1505
  138. Helbich TH, Roberts TP, Gossmann A, et al. Quantitative gadopentetate-enhanced MRI of breast tumors: testing of different analytic methods. Magnetic Resonance in Medicine. 2000;44:915–924
  139. Hellstrom M, Svensson MH, Lasson A. Extracolonic and incidental findings on CT colonography (virtual colonoscopy). AJR American Journal of Roentgenology. 2004;182(3):631–638
  140. Hendrikse NH, Vaalburg W. Dynamics of multidrug resistance: P-glycoprotein analyses with positron emission tomography. Methods. 2002;27(3):228–233
  141. Hennings J, et al. [11C]Metomidate positron emission tomography of adrenocortical tumors in correlation with histopathological findings. Journal of Clinical Endocrinology and Metabolism. 2006;91(4):1410–1414
  142. Henschke CI, Yankelevitz DF, Libby DM, Pasmantier MW, Smith JP. Miettinen OS. Survival of patients with stage I lung cancer detected on CT screening. New England Journal of Medicine. 2006;355(17):1763–1771
  143. Henschke CI, et al. Survival of patients with clinical stage I lung cancer diagnosed by computed tomography screening for lung cancer. Clinical Cancer Research. 2007;13(17):4949–4950
  144. Henschke CI. Computed tomography screening for lung cancer. JAMA. 2007;298(5):514–515
  145. Herbst RS, Mullani NA, Davis DW, et al. Development of biologic markers of response and assessment of antiangiogenic activity in a clinical trial of human recombinant endostatin. Journal of Clinical Oncology. 2002;20:3804–3814
  146. Herrmann K, et al. Early response assessment using 3′-deoxy-3′-[18F]fluorothymidine-positron emission tomography in high-grade non-Hodgkin's lymphoma. Clinical Cancer Research. 2007;13(12):3552–3558
  147. Hillman BJ. Introduction to the Special Issue on Medical Imaging in Oncology. Journal of Clinical Oncology. 2006;24(20):3223–3224
  148. Hillner BE, et al. The National Oncologic PET Registry (NOPR): design and analysis plan. Journal of Nuclear Medicine. 2007;48(11):1901–1908
  149. Hindley J, Gedroyc WM, Regan L, et al. MRI guidance of focused ultrasound therapy of uterine fibroids: early results. AJR American Journal Roentgenology. 2004;183:1713–1719
  150. Hirsch LR, Halas NJ, West JL. Nanoshell-mediated near- infrared thermal therapy of tumors under magnetic resonance guidance. Proceedings of the National Academy of Sciences USA. 2003;100:13549–13554
  151. Ho C-L, et al. 11C-acetate imaging in hepatocellular carcinoma and other liver masses. Nuclear Medicine. 2003;44(2):213–221
  152. Hofmann M, et al. MR-based PET attenuation correction: method and validation. Proceedings of the 2007 IEEE Nuclear Science Symposium and Medical Imaging Conference (NSS-MIC 2007), 6. Los Alamitos, CA, USA: IEEE Computer Society; 2007;
  153. Holdsworth CH, et al. CT and PET: early prognostic indicators of response to imatinib mesylate in patients with gastrointestinal stromal tumor. AJR American Journal of Roentgenology. 2007;189:W324–W330
  154. Hosseinzadeh K, Schwarz SD. Endorectal diffusion-weighted imaging in prostate cancer to differentiate malignant and benign peripheral zone tissue. Journal of Magnetic Resonance Imaging. 2004;20:654–661
  155. Hricak H. MRI and choline-PET of the prostate, Refresher Course 88 Deutsche RoentgenKongress. Fortschritte der Röntgenstrahlen. 2007;179(Suppl.):
  156. Huang SC. Anatomy of SUV. Nuclear Medicine and Biology. 2000;27:643–646
  157. Hui Zhi, et al. Comparison of ultrasound elastography, mammography, and sonography in the diagnosis of solid breast lesions. Journal Ultrasound in Medicine. 2007;26:807–815
  158. Hung SC, et al. Mesenchymal stem cell targeting of microscopic tumors and tumor stroma development monitored by noninvasive in vivo positron emission tomography imaging. Clinical Cancer Research. 2005;11(21):7749–7756
  159. Husarik DB, et al. Evaluation of [18F]-choline PET/CT for staging and restaging of prostate cancer. European Journal of Nuclear Medicine and Molecular Imaging. 2008;35(2):253–263
  160. Hynynen K, et al. Local and reversible blood-brain barrier disruption by noninvasive focused ultrasound at frequencies suitable for trans-skull sonications. Neuroimage. 2005;24(1):12–20
  161. Iinuma G, Ushio K, Ishikawa T, Nawano S, Sekiguchi R, Satake M. Diagnosis of gastric cancers comparison of conventional radiography with a 4 million-pixel charge coupled device. Radiology. 2000;214(2):497
  162. Ilias I, et al. Superiority of 6-[18F]-fluorodopamine positron emission tomography versus [131I]-metaiodobenzylguanidine scintigraphy in the localization of metastatic pheochromocytoma. Journal of Clinical Endocrinology & Metabolism. 2003;88(9):4083–4087
  163. Inoue T, Kim EE, Wallace . S et al. Positron emission tomography using[18F]fluorotamoxifen to evaluate therapeutic responses in patients with breast cancer: preliminary study. Cancer Biotherapy & Radiopharmaceuticals. 1996;11:235–245
  164. Intenzo CM, et al. Scintigraphic imaging of body neuroendocrine tumors. Radiographics. 2007;27:1355–1369
  165. Intes X. Time-domain optical mammography SoftScan: initial results. Academic Radiology. 2005;12(8):934–947(erratum 12(10), 1355)
  166. Itoh A, Ueno E, Tohno E, et al. Breast disease: clinical application of US elastography for diagnosis. Radiology. 2006;239:341–350
  167. Itoh J, Osamura RY. Quantum dots for multicolor tumor pathology and multispectral imaging. Methods in Molecular Biology. 2007;374:29–42
  168. Jacobs AH, et al. 18F-Fluoro-l-thymidine and 11C-methyl-methionine as markers of increased transport and proliferation in brain tumors. Journal of Nuclear Medicine. 2005;46:1948–1958
  169. Jager PL, Vaalburg W, Pruim J, de Vries EG, Langen KJ, Piers DA. Radiolabeled amino acids: basic aspects and clinical applications in oncology. Journal of Nuclear Medicine. 2001;42(3):432–445
  170. Jain M, Batra SK. Genetically engineered antibody fragments and PET imaging: a new era of radioimmunodiagnosis. Journal of Nuclear Medicine. 2003;44(12):1970
  171. Jeffrey FMH, Rajagopal A, Malloy CR, Sherry AD. 13C NMR: a simple yet comprehensive method for analysis of intermediary metabolism. Trends in Biochemical Sciences. 1991;16:5–10
  172. Jennewein M, et al. Vascular imaging of solid tumors in rats with a radioactive arsenic-labeled antibody that binds exposed phosphatidylserine. Clinical Cancer Research. 2008;14:1377–1385
  173. Jensch S, et al. CT colonography with limited bowel preparation: performance characteristics in an increased-risk population. Radiology. 2008;247(1):122–132
  174. Joines WT, Zhang Y, Li C, Jirtle RL. The measured electrical properties of normal and malignant tissues from 50 to 900 MHz. Medical Physics. 1994;21:547–550
  175. Jolesz FA, Hynynen K. Magnetic resonance image-guided focused ultrasound surgery. Cancer Journal. 2002;8:S100–S112
  176. Jolesz FA, Hynynen K, McDannold N, Tempany C. MR imaging-controlled focused ultrasound ablation: a noninvasive image guided surgery. Magnetic Resonance Imaging Clinics of North America. 2006;13:545–560
  177. Jong RA. Contrast-enhanced digital mammography: initial clinical experience. Radiology. 2003;228(3):842–850
  178. Jung KH, et al. Favorable biokinetic and tumor-targeting properties of 99mTc-labeled glucosamino RGD and effect of paclitaxel therapy. Journal of Nuclear Medicine. 2006;47(12):2000–2007
  179. Juweid ME, Wiseman GA, Vose JM, et al. Response assessment of aggressive non-Hodgkin's lymphoma by integrated International Workshop Criteria and fluorine-18-fluorodeoxyglucose positron emission tomography. Journal of Clinical Oncology. 2005;23:4652–4661
  180. Kamat PP, et al. Hepatic embolization in patients with liver metastases. Cardiovascular and Interventional Radiology. 2008;31(2):299–307
  181. Kao TJ, et al. A compensated radiolucent electrode array for combined EIT and mammography. Physiological Measurement. 2007;28(7):S291–S299
  182. Kao TJ, Isaacson D, Newell JC, Saulnier GJ. A 3D reconstruction algorithm for EIT using a handheld probe for breast cancer detection. Physiological Measurement. 2006;27(5):S1–S11
  183. Kato T, Tsukamoto E, Kuge Y, Takei T, Shiga T, Shinohara N, et al. Accumulation of [11C]acetate in normal prostate and benign prostatic hyperplasia: comparison with prostate cancer. European Journal of Nuclear Medicine and Molecular Imaging. 2002;29(11):1492–1495
  184. Kato H, Fukuchi M, Miyazaki T, et al. Prediction of response to definitive chemoradiotherapy in esophageal cancer using positron emission tomography. AntiCancer Research. 2007;27:2627–2633
  185. Kazuhiro P, et al. Classifying pulmonary nodules using dynamic enhanced CT images. IEIC Technical Report (Institute of Electronics, Information and Communication Engineers). 2006;106(105):39–43
  186. Keen HG, Dekker BA, Disley L, et al. Imaging apoptosis in vivo using 124I-annexin V and PET. Nuclear Medicine and Biology. 2005;32:395–402
  187. Keidar Z, Haim N, Guralnik L, Wollner M, Bar-Shalom R, Ben-Nun A, et al. PET/CT using FDG in suspected lung cancer recurrence: diagnostic value and impact on patient management. Journal of Nuclear Medicine. 2004;45:1640–1646
  188. Kemper J, et al. MR elastography of the prostate: initial in-vivo application. Rofo. 2004;176(8):1094–1099
  189. Kenis H, et al. Annexin A5: shifting from a diagnostic towards a therapeutic realm. Cellular and Molecular Life Sciences. 2007;64(22):2859–2862
  190. Kent MS, Port JL, Altorki NK. Current state of imaging for lung cancer staging. Thoracic Surgery Clinics. 2004;14:1–13
  191. Khalkhali I, Baum JK, Villanueva-Meyer J, et al. (99m)Tc sestamibi breast imaging for the examination of patients with dense and fatty breasts: multicenter study. Radiology. 2002;222(1):149–155
  192. Kim SJ, et al. Computer-aided detection in full-field digital mammography sensitivity and reproducibility in serial examinations. Radiology. 2008;246(1):71–79
  193. Kim Y, et al. Multiphase contrast-enhanced CT imaging in hepatocellular carcinoma correlation with immunohistochemical angiogenic activities. Academic Radiology. 2007;14(9):1084–1091
  194. Kinoshita M. Targeted drug delivery to the brain using focused ultrasound. Topics in Magnetic Resonance Imaging. 2006;17(3):209–215
  195. Kircher MF, Mahmood U, King RS, Weissleder R, Josephson LA. Multimodal nanoparticle for preoperative magnetic resonance imaging and intraoperative optical brain tumor delineation. Cancer Research. 2003;63:8122–8125
  196. Kiss G, Van Cleynenbreugel J, Thomeer M, Suetens P, Marchal G. Computer aided diagnosis for virtual colonography. In: MICCAI, Utrecht, The Netherlands. Lecture Notes in Computer Science. 2001;2208: 621
  197. Kob W-J, Rasey JS, Kvans ML, et al. Imaging of hypoxia in human tumors with [18F] fluoromisonidazole. International Journal of Radiation Oncology Biology Physics. 1992;22:199–212
  198. Kolb TM, et al. Comparison of the performance of screening mammography, physical examination, and breast US and evaluation of factors that influence them: an analysis of 27,825 patient evaluations. Radiology. 2002;225:165–175
  199. Kopelman D, Inbar Y, Hanannel A, Dank G, Freundlich D, Perel A, et al. Magnetic resonance-guided focused ultrasound surgery (MRgFUS): four ablation treatments of a single canine hepatocellular adenoma. HPB. 2006;8:292–298
  200. Koukouraki S, et al. Evaluation of the pharmacokinetics of 68Ga-DOTATOC in patients with metastatic neuroendocrine tumours scheduled for 90Y-DOTATOC therapy. European Journal of Nuclear Medicine and Molecular Imaging. 2006;33(4):460–466
  201. Kruger RA, Miller KD, Reynolds HE, Kiser WL, Reinecke DR, Kruger GA. Contrast enhancement of breast cancer in vivo using thermoacoustic CT at 434MHz. Radiology. 2000;216:279–283
  202. Kruse SA, Smith JA, Lawrence AJ, et al. Tissue characterization using magnetic resonance elastography: preliminary results. Physics in Medicine and Biology. 2000;45:1579–1590
  203. Kubota K, Matsuzawa T, Fujiwara T, et al. Differential diagnosis of AH109A tumor and inflammation by radioscintigraphy with l-[methyl-11C]]methionine. Japanese Journal of Cancer Research. 1989;80:778–782
  204. Kuhl CK, Mielcareck P, Klaschik S, et al. Are signal time course data useful for differential diagnosis of enhancing lesions in dynamic breast MR imaging?. Radiology. 1999;211(1):101–110
  205. Kumar R, Shamim SA. Radiolabeled metaiodobenzylguanidine (MIBG) in the diagnosis and treatment of neural crest tumors. Journal of the Academy of Hospital Administration. 2004;16(2):7–12
  206. Kumar S, et al. Biomarkers in cancer screening, research and detection: present and future: a review. Biomarkers. 2006;11(5):385–405
  207. Kurdziel KA, Kiesewetter DO, Carson RE, et al. Biodistribution, radiation dose estimates, and in vivo Pgp modulation studies of 18F-paclitaxel in nonhuman primates. Journal of Nuclear Medicine. 2003;44:1330–1339
  208. Kurhanewicz J, et al. Three dimensional magnetic resonance spectroscopic imaging of brain and prostate cancer. Neoplasia. 2000;2(1-2):166–189
  209. Kushner BH, et al. Impact of metaiodobenzylguanidine scintigraphy on assessing response of high-risk neuroblastoma to dose-intensive induction chemotherapy. Journal of Clinical Oncology. 2003;21(6):1082–1086
  210. Kwan ALC, et al. In:  Flynn MJ editors. Medical Imaging 2005: Physics of Medical Imaging. Proceedings of the SPIE. vol. 5745:2005;p. 1317–1321
  211. Långström B, Itsenko O, Rahman O. [11C]Carbon monoxide, a versatile and useful precursor in labelling chemistry for PET-ligand development. Journal of Labelled Compounds and Radiopharmaceuticals. 2007;50(9-10):794–810
  212. Larsen SS, et al. Endoscopic ultrasound guided biopsy versus mediastinoscopy for analysis of paratracheal and subcarinal lymph nodes in lung cancer staging. Lung Cancer. 2005;48(1):85–92
  213. Larson SM, Erdi Y, Akhurst T, et al. Tumor treatment response based on visual and quantitative changes in global tumor glycolysis using PET-FDG imaging, the visual response score and the change in total lesion glycolysis. Clinical Positron Imaging. 1999;2:159–171
  214. Larson SS, et al. Endoscopic ultrasound guided biopsy of mediastinal lesions has a major impact on patient management. Thorax. 2002;57:98–103
  215. Lauterbur PC. Image formation by induced local interactions: examples employing nuclear magnetic resonance. Nature. 1973;242:190–191
  216. Le Bihan D, Breton E, Syrota A. Imagerie de diffusion par resonance magnetique nucleaire. Les Comptes rendus de l'Académie des sciences. 1985;301:1109–1112
  217. Leach MO. Application of magnetic resonance imaging to angiogenesis in breast cancer. Breast Cancer Research. 2001;3:22–27
  218. Lee KS, Jeong YJ, Han J, Kim BT, Kim H, Kwon OJ. T1 non-small cell lung cancer: imaging and histopathologic findings and their prognostic implications. Radiographics. 2004;24:1617–1636
  219. Lehman CD, et al. Cancer yield of mammography, MR, and US in high-risk women: prospective multi-institution breast cancer screening study. Radiology. 2007;244(2):381–388
  220. Lehtio K, Oikonen V, Gronroos T, et al. Imaging of blood flow and hypoxia in head and neck cancer: initial evaluation with [(15)O]H(2)O and[(18)F]fluoroerythronitroimidazole PET. Journal of Nuclear Medicine. 2001;42:1643–1652
  221. Lehtio K, et al. Quantifying tumour hypoxia with fluorine-18 fluoroerythronitroimidazole ([18F]FETNIM) and PET using the tumour to plasma ratio. European Journal of Nuclear Medicine Molecular Imaging. 2003;30(1):101–108
  222. Lerman H, et al. Improved sentinel node identification by SPECT/CT in overweight patients with breast cancer. Journal of Nuclear Medicine. 2007;48(2):201–206
  223. Lerner RM, Huang SR, Parker KJ. “Sonoelasticity” images derived from ultrasound signals in mechanically vibrated tissues. Ultrasound in Medicine & Biology. 1990;16:231–239
  224. Levchenko A, Mehta BM, Lee JB, et al. Evaluation of 11C-colchicine for PET imaging of multiple drug resistance. Journal of Nuclear Medicine. 2000;41:493–501
  225. Lewin JM, et al. Dual-energy contrast enhanced digital subtraction mammography: feasibility. Radiology. 2003;229(1):261
  226. Li H, Dai H, Xing L, Sinclair R. Characterization of AuFe-C core-shell nanoparticles. Microscopy and Microanalysis. 2006;12:524–525
  227. Li KCP, Pandit SD, Guccione S, Bednarski MD. Molecular imaging applications in nanomedicine. Biomedical Microdevices. 2004;6:113–116
  228. Liapi E, et al. Functional MRI evaluation of tumor response in patients with neuroendocrine hepatic metastases treated with transcatheter arterial chemoembolization. AJR American Journal of Roentgenology. 2008;190(1):67–73
  229. Liberman L, Mason G, Morris EA, et al. Does size matter? Positive predictive value of MRI-detected breast lesions as a function of lesion size. AJR American Journal of Roentgenology. 2006;186(2):426–430
  230. Linden HM, et al. Monitoring targeted therapy: is fluorodeoxyglucose uptake a marker of early response?. Clinical Cancer Research. 2006;12(19):5608–5610
  231. Linden HM, Stekhova SA, Link JM, et al. Quantitative fluoroestradiol positron emission tomography imaging predicts response to endocrine treatment in breast cancer. Journal of Clinical Oncology. 2006;24:2793–2799
  232. Liu J, Levine A, Mattoon J, Yamaguchi M, Lee R, Pan X, et al. Nanoparticles as image enhancing agents for ultrasonography. Physics in Medicine and Biology. 2006;51:2179–2189
  233. Liu J, Li J, Rosol TJ, Pan X, Voorhees JL. Biodegradable nanoparticles for targeted ultrasound imaging of breast cancer cells in vitro. Physics in Medicine and Biology. 2007;52:4739–4747
  234. Liu S. Evaluation of a (99m)Tc-labeled cyclic RGD tetramer for noninvasive imaging integrin alpha(v)beta3-positive breast cancer. Bioconjugate Chemistry. 2007;18(2):438–446
  235. Liu Y, Wang H. Nanotechnology tackles tumours. Nature Nanotechnology. 2007;2(1):20–21
  236. Lo WK, van Sonnenberg E, Shankar S, Morrison PR, Silverman SG, Tuncali K, et al. Percutaneous CT-guided radiofrequency ablation of symptomatic bilateral adrenal metastases in a single session. Journal of Vascular and Interventional Radiology. 2006;17:175–179
  237. Lorenz A, et al. Ultrasound elastography of the prostate. A new technique for tumor detection. Ultraschall in der Medizin. 2000;21(1):8–15
  238. Lövqvist A, et al. PET imaging of 86Y-labeled anti-Lewis Y monoclonal antibodies in a nude mouse model: comparison between 86Y and 111In radiolabels. Journal of Nuclear Medicine. 2001;42(8):1281–1286
  239. Luo J, et al. Elasticity reconstruction for ultrasound elastography using a radial compression: an inverse approach. Ultrasonics. 2006;44(Suppl. 1):e195–e198
  240. Machulla HJ, Blocher A, Kuntzsch M, Piert M, Wei R, Grierson JR. Simplified labeling approach for synthesizing 39-deoxy-39-[18F]fluorothymidine ([18F]FLT). Journal of Radioanalytical and Nuclear Chemistry.,243. 2000;843–846
  241. MacMahon H. Dual-energy and temporal subtraction digital chest radiography. In:  Samei E,  Flynn MJ editor. Syllabus: Advances in Digital Radiography: RSNA Categorical Course in Diagnostic Radiology Physics. RSNA Publications; 2003;p. 181–188
  242. Manohar S, Kharine A, van Hespen JCG, Steenbergen W, van Leeuven TG. The Twente photoacoustic mammoscope: system overview and performance. Physics in Medicine and Biology. 2005;50:2543–2557
  243. Manohar S, Vaartjes SE, van Hespen JCG, Klaase JM, van den Engh FM, Steenbergen W, et al. Initial results of in vivo non-invasive cancer imaging in the human breast using near-infrared photoacoustics. Optics Express. 2007;15(19):12277–12285
  244. Mar MV, et al. Evaluation and localization of lymphatic drainage and sentinel lymph nodes in patients with head and neck melanomas by hybrid SPECT/CT lymphoscintigraphic imaging. Journal of Nuclear Medicine Technology. 2007;35(1):10–16
  245. Marchetti S, Schellens JH. The impact of FDA and EMEA guidelines on drug development in relation to Phase 0 trials. British Journal of Cancer. 2007;97:577–581
  246. Mardor, Y., 2003. Proceedings of the American Association for Cancer Research 41 (abstract 2547).
  247. Mariani G, et al. Radioguided sentinel lymph node biopsy in breast cancer surgery. Journal of Nuclear Medicine. 2001;42:1198–1215
  248. Martínez-Möller A, et al. An approach for MR-based attenuation correction for combined MR/PET: effects of ignoring bones. Journal of Nuclear Medicine. 2007;48(Suppl. 2):156P
  249. Maskell N, Gleeson F, Davies R. CT-guided biopsy for diagnosis of malignant disease in pleural effusions. Lancet. 2003;362:174
  250. Masuzaki R, et al. Assessing liver tumor stiffness by transient elastography. Hepatology International. 2007;1(3):394–397
  251. Matoba M, et al. Lung carcinoma: diffusion-weighted MR imaging – preliminary evaluation with apparent diffusion coefficient. Radiology. 2007;243(2):570–577
  252. Matsuki M, et al. Diffusion-weighed MR imaging of pancreatic carcinoma. Abdominal Imaging. 2007;32(4):481–483
  253. Matsuki M, et al. Diffusion-weighted MR imaging for urinary bladder carcinoma: initial results. European Radiology. 2007;17(1):201–204
  254. McDannold N, Moss M, Killiany R, et al. MRI-guided focused ultrasound surgery in the brain: tests in a primate model. Magnetic Resonance in Medicine. 2003;49(6):1188–1191
  255. McDermott GM, Welch A, Staff RT, et al. Monitoring primary breast cancer throughout chemotherapy using FDG-PET. Breast Cancer Research and Treatment. 2007;102:75–84
  256. McGee KP, Hubmayr RD, Ehman RL. MR elastography of the lung with hyperpolarized 3He. Magnetic Resonance in Medicine. 2007;59(1):14–18
  257. McKnight AL, et al. MR elastography of breast cancer: preliminary results. AJR American Journal of Roentgenology. 2002;178:1411–1417
  258. Melodelima D, et al. Using intraluminal ultrasound for the treatment of esophageal tumors: first clinical results. Ultrasonics Symposium 2006 IEEE. 2006;740–743
  259. Mercadante S, et al. CT-guided neurolytic splanchnic nerve block by an anterior approach. Journal of Pain and Symptom Management. 2002;23(4):268–270
  260. Meyer B, et al. Contrast-enhanced abdominal angiographic CT for intra-abdominal tumor embolization: a new tool for vessel and soft tissue visualization. Cardiovascular and Interventional Radiology. 2007;30:743–749
  261. Miller JC, Pien HH, Sahani D, Sorensen AG, Thrall JH. Imaging angiogenesis: applications and potential for drug development. Journal of the National Cancer Institute. 2005;97:172–187
  262. Minami K. Computerized characterization of contrast enhancement patterns for classifying pulmonary nodules. Proceedings of 2001 International Conference on Image Processing. 2001;vol. 2:897–900
  263. Min-Ho Lee, Nammalvar V, Gobin A, Barton J, West J, Drezek R. Nanoshells as contrast agents for scatter-based optical imaging. In: 3rd IEEE International Symposium on Biomedical Imaging: Nano to Macro. 2006;p. 371–374
  264. Mintun MA, Welch MJ, Siegel BA, et al. Breast cancer: PET imaging of estrogen receptors. Radiology. 1988;169:45–48
  265. Miyanaga N, Akaza H, Yamakawa M, Oikawa T, Sekido N, Hinotsu S, et al. Tissue elasticity imaging for diagnosis of prostate cancer: a preliminary report. International Journal of Urology. 2006;13(12):1514–1518
  266. Moehler M, Dimitrakopoulou-Strauss A, Gutzler F, et al. 18F-labeled fluorouracil positron emission tomography and the prognoses of colorectal carcinoma patients with metastases to the liver treated with 5-fluorouracil. Cancer. 1998;83:245–253
  267. Moffat BA, et al. Functional diffusion map: a noninvasive MRI biomarker for early stratification of clinical brain tumor response. Proceedings of the National Academy of Sciences USA. 2005;102:5524–5529
  268. Morris E. Breast cancer. In:  Edelman R,  Hesselink J,  Zlatkin M editor. Clinical Magnetic Resonance Imaging. Philadelphia, PA: Elsevier Publishing; 2006;p. 2426–2454
  269. Mulder WJM, et al. Quantum dots with a paramagnetic coating as a bimodal molecular imaging probe. Nano Letters. 2006;6:1–6
  270. Murakami Y, et al. 18F labeled annexin V: a PET tracer for apoptosis imaging. European Journal of Nuclear Medicine and Molecular Imaging. 2004;31(4):469–474
  271. Muthupillai R, Lomas DJ, Rossman PJ, Greenleaf JF, Manduca A, Ehman RL. Magnetic resonance elastography by direct visualization of propagating acoustic strain waves. Science. 1995;269:1854–1857
  272. Narayan P, et al. The role of transrectal ultrasound-guided based-staging, preoperative prostate serum antigen, and biopsy Gleason score in prediction of final pathologic diagnosis of prostate cancer. Urology. 1995;46(2):205–212
  273. Nelson ED, Slotoroff CB, Gomella LG, Halpern EJ. Targeted biopsy of the prostate: the impact of color Doppler imaging and elastography on prostate cancer detection and Gleason score. Urology. 2007;70(6):1136–1140
  274. Nelson JL, Roeder BL, Carmen JC, Roloff F, Pitt WG. Ultrasonically activated chemotherapeutic drug delivery in a rat model. Cancer Research. 2002;62:7280–7283
  275. Nelson SJ, et al. Volume MRI and MRSI techniques for the quantitation of treatment response in brain tumors: presentation of a detailed case study. Journal of Magnetic Resonance Imaging. 1997;7:1164–1152
  276. Neuwalt EA, et al. Imaging of iron oxide nanoparticles with MR and light microscopy in patients with malignant brain tumors. Neuropathology and Applied Neurobiology. 2004;5:456–471
  277. Neves AA, Brindle KM. Assessing responses to cancer therapy using molecular imaging. Biochimica Biophysica Acta. 2006;1766:242–261
  278. Ning R, et al. In:  Flynn MJ,  Hsieh J editor. Medical Imaging 2006: Physics of Medical Imaging. Proceedings of the SPIE. vol. 6142:2006;p. 348–356
  279. Nomori H, et al. 11C-acetate positron emission tomography imaging for lung adenocarcinoma 1 to 3 cm in size with ground-glass opacity images on computed tomography. Annals of Thoracic Surgery. 2005;80:2020–2025
  280. Ntziachristos V, Yodh AG, Schnall MD, Chance B. MRI-guided diffuse optical spectroscopy of malignant and benign breast lesions. Neoplasia. 2002;4(4):347–354
  281. Nunes LW. Architectural-based interpretations of breast MR imaging. Magnetic Resonance Imaging Clinics of North America. 2001;9(2):303–320
  282. O'Connor MK, Phillips SW, Hruska CB, et al. Molecular breast imaging: advantages and limitations of a scintimammographic technique in patients with small breast tumors. Breast Journal. 2007;13(1):3–11
  283. Ohtani T, Kurihara H, Ishiuchi S, Saito N, Oriuchi N, Inoue T, et al. Brain tumour imaging with carbon-11 choline: comparison with FDG PET and gadolinium-enhanced MR imaging. European Journal of Nuclear Medicine. 2001;28:1664–1670
  284. Okada A, Murakami T, Mikami K, Onishi H, Tanigawa N, Marukawa T. Nakamura H. A case of hepatocellular carcinoma treated by MR guided focused ultrasound ablation with respiratory gating. Magnetic Resonance in Medical Sciences. 2006;5(3):167–171
  285. Oraevsky AA, et al. Optoacoustic imaging of blood for visualization and diagnostics of breast cancer. Proc. SPIE. 2002;4618:81–94
  286. Oyama N, Miller TR, Dehdashti F, Siegel BA, Fischer KC, Michalski JM, et al. 11C-acetate PET imaging of prostate cancer: detection of recurrent disease at PSA relapse. Journal of Nuclear Medicine. 2003;44(4):549–555
  287. Paajanen H. Increasing use of mammography improves the outcome of breast cancer in Finland. The Breast Journal. 2006;12(1):88–90
  288. Padhani AR, Leach MO. Antivascular cancer treatments: functional assessments by dynamic contrast enhanced MRI. Abdominal Imaging. 2005;30:324–341
  289. Padhani AR, et al. . Changes in tumour vascular permeability with antiangiogenesis therapy: observations on histogram analysis. In: Proceedings of the Eighth International Society of Magnetic Resonance in Medicine, April 3–7, 2000. Berkeley, CA: Denver. ISMRM; 2000;108
  290. Padhani AR, et al. Response of breast carcinoma to chemotherapy: MR permeability changes using histogram analysis. In: Proceedings of the Eighth International Society of Magnetic Resonance in Medicine, April 3–7, 2000. Berkeley, CA: Denver. ISMRM; 2000;p. 2160
  291. Paganelli G, et al. IART®: Intraoperative avidination for radionuclide treatment. A new way of partial breast irradiation. The Breast. 2007;16:17–26
  292. Paliwal S, Sundaram J, Mitragotri S. Induction of cancer-specific cytotoxicity towards human prostate and skin cells using quercetin and ultrasound. British Journal of Cancer. 2005;92(3):499–502
  293. Pallwein L, Mitterberger M, Struve P, Pinggera G, Horninger W, Bartsch G, et al. Real-time elastography for detecting prostate cancer: preliminary experience. BJU International. 2007;100(1):42–46
  294. Palmeri M, et al. Acoustic radiation force impulse (ARFI) imaging of the gastrointestinal tract. Ultrasonics Symposium 2004 IEEE. 2004;vol. 1:744–747
  295. Pappo I, Horne T, Weissberg D, Wasserman I, Orda R. The usefulness of MIBI scanning to detect underlying carcinoma in women with acute mastitis. Breast Journal. 2000;6:126–129
  296. Passchier J, Lawrie K, Bender D, Fellows I, Gee A. [11C]Loperamide as highly sensitive PETprobe for measuring changes in P-glycoprotein functional. Journal of Labelled Compounds and Radiopharmaceuticals. 2003;46:S403
  297. Pech M, et al. Synchronous CT-guided brachytherapy in patients at risk for incomplete interstitial laser ablation of liver malignancies. Medical Laser Application. 2004;19(2):78–32
  298. Pham C, Roberts T, van Bruggen N, Melnyk O, Mann J, Ferrara N, et al. Magnetic resonance imaging detects suppression of tumor vascular permeability after administration of antibody to vascular endothelial growth factor. Cancer Investigation. 1998;16:225–230
  299. Piao D, et al. Near-infrared optical tomography: endoscopic imaging approach. Proc. SPIE. 2007;6431:643103–1-643103-10
  300. Pierce DA, Shimizu Y, Preston DL, et al. Studies of the mortality of atomic bomb survivors: report 12, Part 1 – Cancer: 1950–1990. Radiation Research. 1996;146:1–27
  301. Pineda AR, et al. Optimization of a tomosynthesis system for the detection of lung nodules. Medical Physics. 2006;33(5):1372–1379
  302. Pisano ED, et al. Digital Mammographic Imaging Screening Trial (DMIST) investigators group. Diagnostic performance of digital versus film mammography for breast-cancer screening. New England Journal of Medicine. 2005;353(17):1773–1783
  303. Plewes DB, Bishop J, Samani A, Sciarretta J. Visualization and quantification of breast cancer biomechanical properties with magnetic resonance elastography. Physics in Medicine and Biology. 2000;45:1591–1610
  304. Pogue BW, Poplack SP, McBride TO, Wells WA, Osterman KS, Osterberg UL, et al. Quantitative hemoglobin tomography with diffuse near-infrared spectroscopy: pilot results in the breast. Radiology. 2001;218:261–266
  305. Poplack SP, et al. Electromagnetic breast imaging: average tissue property values in women with negative clinical findings. Radiology. 2004;231(2):571–580
  306. Poplack SP, et al. Electromagnetic breast imaging: results of a pilot study in women with abnormal mammograms. Radiology. 2007;243(2):350–359
  307. Provenzale JM, Wang GR, Brenner T, Petrella JR, Sorensen AG. Comparison of permeability in high-grade and low-grade brain tumors using dynamic susceptibility contrast MRI. AJR American Journal of Roentgenology. 2002;178:711–716
  308. Provenzale JM, Mukundan S, Barboriak D. Diffusion-weighted and perfusion MR imaging for brain tumor characterization and assessment of treatment response. Radiology. 2006;239:632–649
  309. Rabin O, Manuel Perez J, Grimm J, et al. An X-ray computed tomography imaging agent based on long-circulating bismuth sulphide nanoparticles. Nature Materials. 2006;5:118–122
  310. Rafferty AE. Digital mammography: novel applications. Radiologic Clinics of North America. 2007;45(5):831–843
  311. Rago T, et al. Elastography: new developments in ultrasound for predicting malignancy in thyroid nodules. Journal of Clinical Endocrinology & Metabolism. 2007;92(8):2917–2922
  312. Rajendran JG, et al. Hypoxia imaging-directed radiation treatment planning. European Journal of Nuclear Medicine and Molecular Imaging. 2006;33(Suppl. 1):44–53
  313. Rallan D, Dickson M, Bush NL, Harland CC, Mortimer P, Bamber JC. High-resolution ultrasound reflex transmission imaging and digital photography: potential tools for the quantitative assessment of pigmented lesions. Skin Research and Technology. 2006;12(1):50–59
  314. Rapoport NY, Christensen DA, Fain HD, Barrows L, Gao Z. Ultrasound-triggered drug targeting of tumors in vitro and in vivo. Ultrasonics. 2004;42:943–950
  315. Rapoport N, et al. Multifunctional nanoparticles for combining ultrasonic tumor imaging and targeted chemotherapy. Journal of the National Cancer Institute. 2007;99(14):1095–1106
  316. Raylman RR, et al. The positron emission mammography/tomography breast imaging and biopsy system (PEM/PET): design, construction and phantom-based measurements. Physics in Medicine and Biology. 2008;53:637–653
  317. Reeves AP. The Lung Image Database Consortium (LIDC): a comparison of different size metrics for pulmonary nodule measurements. Academic Radiology. 2007;14(12):1475–1485
  318. Rhodes DJ, O'Connor MK, Phillips SW, et al. Molecular breast imaging: a new technique using technetium Tc 99m scintimammography to detect small tumors of the breast. Mayo Clinic Proceedings. 2005;80(1):24–30
  319. Ricke J, et al. CT-guided interstitial brachytherapy of liver malignancies alone or in combination with thermal ablation: phase I–II results of a novel technique. International Journal of Radiation Oncology Biology Physics. 2004;58(5):1496–1505
  320. Rinneberg H, et al. Scanning time-domain optical mammography: detection and characterization of breast tumors in vivo. Technology in Cancer Research & Treatment. 2005;4(5):483–496
  321. Rizk N, Downey RJ, Akhurst T, et al. Preoperative [18F]-fluorodeoxyglucose positron emission tomography standardized uptake values predict survival after esophageal adenocarcinoma resection. Annals of Thoracic Surgery. 2006;81:1076–1081
  322. Ro RJ, et al. Assessing angiogenesis in murine glioma and breast tumor models with contrast enhanced ultrasound imaging. Ultrasonics Symposium 2006 IEEE. 2006;416–419
  323. Robbins RJ, Wan Q, Grewal RK, et al. Real-time prognosis for metastatic thyroid carcinoma based on 2-[18F]fluoro-2-deoxy-d-glucose-positron emission tomography scanning. Journal of Clinical Endocrinology and Metabolism. 2006;91:498–505
  324. Robinson MK, et al. Quantitative immuno-positron emission tomography imaging of HER2-positive tumor xenografts with an iodine-124 labeled anti-HER2 diabody. Cancer Research. 2005;65(4):1471–1478
  325. Rogers WJ, Meyer CH, Kramer CM. Technology insight: in vivo cell tracking by use of MRI. Nature Clinical Practice. Cardiovascular Medicine. 2006;3(10):554–562
  326. Ross RJ, Thompson JS, Kim K, Bailey RA. Nuclear magnetic resonance imaging and evaluation of human breast tissue: preliminary clinical trials. Radiology. 1982;143:195–205
  327. Rossi CR, et al. The impact of lymphoscintigraphy technique on the outcome of sentinel node biopsy in 1,313 patients with cutaneous melanoma: an Italian multicentric study (SOLISM-IMI). Journal of Nuclear Medicine. 2006;47:234–241
  328. Rousseau C, Devillers A, Sagan C, et al. Monitoring of early response to neoadjuvant chemotherapy in stage II and III breast cancer by [18F]fluorodeoxyglucose positron emission tomography. Journal of Clinical Oncology. 2006;24:5366–5372
  329. Sãftoiu A, Vilman P. Endoscopic ultrasound elastography – a new imaging technique for the visualization of tissue elasticity distribution. Journal of Gastrointestinal and Liver Diseases. 2006;15(2):161–165
  330. Salomir R, et al. Image-based control of the magnetic resonance imaging-guided focused ultrasound thermotherapy. Topics in Magnetic Resonance Imaging. 2006;17(3):139–151
  331. Samei E, et al. Multiprojection correlation imaging for improved detection of pulmonary nodules. AJR American Journal of Roentgenology. 2007;188:1239–1245
  332. Sampalis FS, Denis R, Picard D, et al. International prospective evaluation of scintimammography with technetium sestamibi. American Journal of Surgery. 2003;185:544–549
  333. Sandblom G, et al. Positron emission tomography with C11-acetate for tumor detection and localization in patients with prostate-specific antigen relapse after radical prostatectomy. Urology. 2006;67(5):996–1000
  334. Sarapa N, Hsyu P-H, Lappin G, Garner RC. The application of accelerator mass spectrometry to absolute bioavailability studies in humans: simultaneous administration of an intravenous microdose of 14C-Nelfinavir mesylate solution and oral Nelfinavir to healthy volunteers. Journal of Clinical Pharmacology. 2005;45:1198–1205
  335. Sarkeala T, et al. Breast cancer mortality with varying invitational policies in organised mammography. British Journal of Cancer. 2008;98:641–645
  336. Schellenberger EA, et al. Annexin V-CLIO: a nanoparticle for detecting apoptosis by MRI. Molecular Imaging. 2002;1:102–107
  337. Schoder H, Noy A, Gonen M, et al. Intensity of 18-F fluorodeoxyglucose uptake in positron emission tomography distinguishes between indolent and aggressive non-Hodgkin's lymphoma. Journal of Clinical Oncology. 2005;23:4643–4651
  338. Scholz M, et al. Vibrography during tumor neurosurgery. Journal of Ultrasound in Medicine. 2005;24:985–992
  339. Shah SK. Computer aided characterization of the solitary pulmonary nodule using volumetric and contrast enhancement features. Academic Radiology. 2005;12(10):1310–1319
  340. Shim SS, Lee KS, Kim B, Lee EJ, Choi JY, Chung MJ. Accuracy of integrated PET/CT using fluorodeoxyglucose in preoperative staging on non-small cell lung cancer: a prospective comparison with standalone CT. Radiology. 2004;233:383;abstract SSE04-02
  341. Shulkin BL, Wienland DM, Shapiro B, Sisson JC. PET epinephrine studies of pheochromocytoma. Journal of Nuclear Medicine. 1995;36:229P
  342. Shulkin BL, et al. Current concepts on the diagnostic use of MIBG in children. Journal of Nuclear Medicine. 1998;39:679–688
  343. Silverman SG, et al. MR imaging-guided percutaneous cryotherapy of liver tumors: initial experience. Radiology. 2000;217:657–664
  344. Simon C, Dupuy D. Percutaneous minimally invasive therapies in the treatment of bone tumors: thermal ablation. Seminars in Musculoskeletal Radiology. 2006;10:137–144
  345. Sinkus R, Lorenzen J, Schrader D, Lorenzen M, Dargatz M, Holz D. High-resolution tensor MR elastography for breast tumour detection. Physics in Medicine and Biology. 2000;45:1649–1664
  346. Slovis TL. Conference on the ALARA (as low as reasonably achievable) concept in pediatric CT: intelligent dose reduction. Pediatric Radiology. 2002;32:217–218
  347. Smith JJ, Sorensen AG, Thrall JH. Biomarkers in imaging: realizing radiology's future. Radiology. 2003;227(3):633–638
  348. Sorger D, Patt M, Kumar P, et al. [18F]fluoroazomycinarabinofuranoside (18FAZA) and [18F]fluoromisonidazole (18FMISO): a comparative study of their selective uptake in hypoxic cells and PET imaging in experimental rat tumors. Nuclear Medicine and Biology. 2003;30:317–326
  349. Souvatzoglou M, Grosu AL, Roper B, et al. Tumour hypoxia imaging with[(18)F]FAZA PET in head and neck cancer patients: a pilot study. European Journal of Nuclear Medicine Molecular Imaging. 2007;34:1566–1575
  350. Srinivas PR, Barker P, Srivastava S. Nanotechnology in early detection of cancer Laboratory Investigation. 2002;82:657–662
  351. Stadnik T, et al. Breast imaging. Preoperative breast cancer staging: comparison of USPIO- enhanced MR imaging and 18F-fluorodeoxyglucose (FDG) positron emission tomography (PET) imaging for axillary lymph node staging – initial findings. European Radiology. 2006;16(10):2153–2160
  352. Stattaus J, et al. CT guided biopsy of small liver lesions: visibility, artifacts and corresponding diagnostic accuracy. Cardiovascular and Interventional Radiology. 2007;30(5):928–935
  353. Steffen AC, Wikman M, Tolmachev V, et al. In vitro characterization of a bivalent anti-HER-2 affibody with potential for radionuclide-based diagnostics. Cancer Biotherapy & Radiopharmaceuticals. 2005;20:239–248
  354. Stroobants S, et al. (18)FDG-Positron emission tomography for the early prediction of response in advanced soft tissue sarcoma treated with imatinib mesylate (Glivec). European Journal of Cancer. 2003;39:2012–2020
  355. Su H, Bodenstein C, Dumont R, et al. Monitoring tumor glucose utilization by positron emission tomography for the prediction of treatment response to epidermal growth factor receptor kinase inhibitors. Clinical Cancer Research. 2006;12:5659–5667
  356. Su MY, et al. Tumor characterization with dynamic contrast-enhanced MRI using MR contrast agents of various molecular weights. Magnetic Resonance in Medicine. 1998;39(2):259–269
  357. Su M-Y, Taylor JA, Villarreal LP, Nalcioglu O. Prediction of gene therapy-induced tumor size changes by the vascularity changes measured using dynamic contrast-enhanced MRI. Magnetic Resonance Imaging. 2000;18:311–317
  358. Suh Y, Weiss E, Keall P. A deliverable 4D IMRT planning method for DMLC tumor tracking delivery. International Journal of Radiation Oncology Biology Physics. 2007;69(3):S190–S191
  359. Sun H, et al. Imaging DNA synthesis with [18F]FMAU and positron emission tomography in patients with cancer. European Journal of Nuclear Medicine Molecular Imaging. 2005;32(1):15–22
  360. Sundaresan G, Yazaki PJ, Shively JE, et al. 124I-labeled engineered anti-CEA minibodies and diabodies allow high-contrast, antigen-specific small-animal PET imaging of xenografts in athymic mice. Journal of Nuclear Medicine. 2003;44:1962–1969
  361. Suyash K, et al. Percutaneous computed tomography-guided core biopsy for the diagnosis of mediastinal masses. Annals of Thoracic Medicine. 2008;3(1):13–17
  362. Suzuki K, Li F, Sone S, Doi K. Computer-aided diagnostic scheme for distinction between benign and malignant nodules in thoracic low-dose CT by use of massive training artificial neural network. Medical Imaging. 2005;24(9):1138–1150
  363. Sweeney KJ, Sacchini V. Is there a role for magnetic resonance imaging in a population-based breast cancer screening program?. Breast Journal. 2007;13(6):543–544
  364. Swensen SJ. Functional CT: Lung nodule evaluation. RadioGraphics. 2000;20:1178–1181
  365. Swensen SJ, et al. Lung cancer screening with CT: Mayo Clinic experience. Radiology. 2003;226(3):756–761
  366. Tachibana K, et al. Enhanced cytotoxic effect of Ara-C by low intensity ultrasound to HL-60 cells. Cancer Letters. 2000;149:189–194
  367. Takano A, Kusuhara H, Suhara T, et al. Evaluation of in vivo P-glycoprotein function at the blood–brain barrier among MDR1 gene polymorphisms by using 11C-verapamil. Journal of Nuclear Medicine. 2006;47:1427–1433
  368. Takayoshi U, et al. Dynamic contrast enhanced screening of microcalcifications in the breast. Is there any value?. Breast Cancer Research and Treatment. 2007;103(3):269–281
  369. Tam A, Ahra K. Palliative interventions for pain in cancer patients. Seminars in Interventional Radiology. 2007;24(4):419–429
  370. Tardivon AA, Ollivier L, El Khoury C, Thibault F. Monitoring therapeutic efficacy in breast carcinomas. European Radiology. 2006;16:2549–2558
  371. Tata DB, et al. Selective clinical ultrasound signals mediate differential gene transfer and expression in two human prostate cancer cell lines: LnCap and PC-3. Biochemical and Biophysical Research Communications. 1997;234(1):64–67
  372. Tatum JL, Hoffman JM. Congressional update-report from the biomedical imaging program of the National Cancer Institute—imaging drug development. Academic Radiology 7: 1007-1008 (2000).
  373. Taylor S, et al. CT colonography: investigation of the optimum reader paradigm by using computer-aided detection software. Radiology. 2008;246(2):463–471
  374. Tedeschi G, et al. Increased choline signal corresponding to malignant degeneration of cerebral gliomas: a serial proton magnetic resonance spectroscopy imaging study. Journal of Neurosurgery. 1997;87:516–524
  375. Teeuwisse WM, et al. Patient and staff dosage during CT guided biopsy, drainage and coagulation. British Journal of Radiology. 2001;74(884):720
  376. Therasse P, Arbuck SG, Eisenhauer EA, Wanders J, Kaplan RS, Rubinstein L, et al. New guidelines to evaluate the response to treatment in solid tumors. Journal of the National Cancer Institute. 2000;92(3):205–216
  377. Thorwarth D, Eschmann SM, Paulsen F, et al. A kinetic model for dynamic [18F]-FMISO PET data to analyse tumour hypoxia. Physics in Medicine and Biology. 2005;50:2209–2224
  378. Tillmann L, et al. Transrectal ultrasound guided biopsy of the prostate: random sextant versus biopsies of sono-morphologically suspicious lesions. World Journal of Urology. 2004;22(5):357–360
  379. Trampal C, et al. Pheochromocytomas detection hydroxyephedrine PET with 11C. Radiology. 2004;230(2):423–428
  380. Tromberg BJ, et al. Noninvasive in vivo characterization of breast tumors using photon migration spectroscopy. Neoplasia. 2000;2:26–40
  381. Tromberg BJ, et al. Non-invasive measurements of breast tissue optical properties using frequency-domain photon migration. Philosophical Transactions of the Royal Society of London B. 1997;352:661–668
  382. Tsutsumi M, Miyagawa T, Matsumura T, Kawazoe N, Ishikawa S, Shimokama T, et al. The impact of real-time tissue elasticity imaging (elastography) on the detection of prostate cancer: clinicopathological analysis. International Journal of Clinical Oncology. 2007;12(4):250–255
  383. Turetschek K, Preda A, Floyd E, et al. MRI monitoring of tumor response following angiogenesis inhibition in an experimental human breast cancer model. European Journal of Nuclear Medicine and Molecular Imaging. 2003;30:448–455
  384. US Food and Drug Administration . Guidance for Industry, Investigators, and Reviewers. Exploratory IND Studies. Center for Drug Evaluation and Research. Washington, DC: US Department of Health and Human Services; 2006;1–16
  385. van der Ploeg IMC, et al. The additional value of SPECT/CT in lymphatic mapping in breast cancer and melanoma. Journal of Nuclear Medicine. 2007;48(11):1756–1760
  386. van Wamel A, Bouakaz A, Bernard B, ten Cate F, de Jong N. Radionuclide tumour therapy with ultrasound contrast microbubbles. Ultrasonics. 2004;42:903–906
  387. Velikyan I, Beyer GJ, Langstrom B. Microwave-supported preparation of 68Ga bioconjugates with high specific radioactivity. Bioconjugate Chemistry. 2004;15:554–560
  388. Vielvoye-Kerkmeer APE. CT guided neurolytic splanchnic nerve block. Journal of Pain and Symptom Management. 2002;24(5):455
  389. Virmani S, et al. Effect of C-arm angiographic CT on transcatheter arterial chemoembolization of liver tumors. Journal of Vascular and Interventional Radiology. 2007;18(10):1305–1309
  390. Vogl TJ. Prostate cancer: MR imaging-guided galvanotherapy – technical development and first clinical results. Radiology. 2007;245(3):895–902
  391. Volterrani L, et al. Three-dimensional analysis of pulmonary nodules by MSCT with Advanced Lung Analysis (ALA1) software. La Radiologia medica. 2006;111(3):343–354
  392. von Rahden B, Sarbia M, Stein H. Combined FDG-PET/CT and CT-guided biopsy in diagnosing oesophageal cancer recurrence. Journal of the New Zealand Medical Association. 2006;119:1228
  393. Vormola R, et al. Correlation of 11C-choline PET and PSA values in patients with prostate cancer and biochemical relapse after primary treatments. 2007 ASCO Annual Meeting Proceedings. Journal of Clinical Oncology. 2007;25(18S):5073
  394. Wadsak W, et al. [18F]FETO for adrenocortical PET imaging: a pilot study in healthy volunteers. European Journal of Nuclear Medicine and Molecular Imaging. 2006;33(6):669–672
  395. Wald LL, et al. Serial proton magnetic resonance spectroscopy imaging of glioblastoma multiforme after brachytherapy. Journal of Neurosurgery. 1997;87:525–534
  396. Wallace MJ. C-arm computed tomography for guiding hepatic vascular intervention. Techniques in Vascular and Interventional Radiology. 2007;10(1):79–86
  397. Wallace MJ, et al. Impact of C-arm CT on hepatic arterial interventions for hepatic malignancies. Journal of Vascular and Interventional Radiology. 2007;18(12):1500–1507
  398. Wang LV, Wu HI. Biomedical Optics. Wiley-Interscience; 2007;
  399. Weichert J, et al. Radioiodinated NM404 – a universal tumor imaging agent?. Academic Radiology. 2005;12(5):S58–S59
  400. Weller GER, et al. Ultrasonic imaging of tumor angiogenesis using contrast microbubbles targeted via the tumor-binding peptide arginine-arginine-leucine. Cancer Research. 2005;65:533–539
  401. Wells P, West C, Jones T, et al. Measuring tumor pharmacodynamic response using PET proliferation probes: the case for 2-[(11)C]-thymidine. Biochimica Biophysica Acta. 2004;1705:91–102
  402. Wheatley MA, Forsberg F, Dube N, Patel M, Oeffinger BE. Surfactant-stabilized contrast agent on the nanoscale for diagnostic ultrasound imaging. Ultrasound in Medicine & Biology. 2006;32:83–93
  403. Wieder HA, et al. Prediction of tumor response by FDG-PET: comparison of the accuracy of single and sequential studies in patients with adenocarcinomas of the esophagogastric junction. European Journal of Nuclear Medicine and Molecular Imaging. 2007;34(12):1925–1932
  404. Wiegel T. 11C-choline PET-CT for diagnosis of local recurrence following PSA increase after radical prostatectomy: implications for radiotherapy. ASCO 2007 Prostate Cancer Symposium, abstract 178.
  405. Willemsen AT, van-Waarde A, Paans AM, et al. In vivo protein synthesis rate determination in primary or recurrent brain tumors using l-[1-11C]-tyrosine and PET. Journal of Nuclear Medicine. 1995;36:411–419
  406. Williams DB, et al. Endoscopic ultrasound guided fine needle aspiration biopsy: a large single centre experience. Gut. 1999;44:720–726
  407. Win Z, et al. 68Ga-DOTATATE PET in neuroectodermal tumours: first experience. Nuclear Medicine Communications. 2007;28(5):359–363
  408. Wong CY, Schmidt J, Bong JS, et al. Correlating metabolic and anatomic responses of primary lung cancers to radiotherapy by combined F-18 FDG PET-CT imaging. Radiation Oncology. 2007;2:18
  409. Wong SH, et al. Capacitive micromachined ultrasonic transducers for high intensity focused ablation of upper abdominal tumors. Ultrasonics Symposium 2006 IEEE, pp. 841–844 (2006).
  410. Wong TZ, et al. ProstaScint (capromab pendetide) imaging using hybrid gamma camera-CT technology. AJR American Journal of Roentgenology. 2005;184(2):676–680
  411. Wu AM, Yazaki PJ, Tsai S, et al. High-resolution microPET imaging of carcinoembryonic antigen-positive xenografts by using a copper-64-labeled engineered antibody fragment. Proceedings of the National Academy of Sciences USA. 2000;97:8495–8500
  412. Wu F, et al. Expression of tumor antigens and heat-shock protein 70 in breast cancer cells after high-intensity focused ultrasound ablation. Annals of Surgical Oncology. 2007;14:1237–1242
  413. Tian Xiaobing, et al. External imaging of CCND1 cancer gene activity in experimental human breast cancer xenografts with 99mTc-peptide-peptide nucleic acid-peptide chimeras. Journal of Nuclear Medicine. 2004;45:2070–2082
  414. Xiong T, et al. Incidental lesions found on CT colonography: their nature and frequency. British Journal of Radiology. 2005;78:22–29
  415. Xu M, Wang LV. Photoacoustic imaging in biomedicine. Review of Scientific Instruments. 2006;77(041101):
  416. Xu Y, Wang LV. Rhesus monkey brain imaging through intact skull with thermoacoustic tomography. IEEE Transactions on Ultrasonics. Ferroelectrics and Frequency Control. 2006;53:542–548
  417. Xydeas T, et al. Magnetic resonance elastography of the breast: correlation of signal intensity data with viscoelastic properties. Rofo. 2005;40(7):412–420
  418. Yagle KJ, Eary JF, Tait JF, et al. Evaluation of 18F-annexin V as a PET imaging agent in an animal model of apoptosis. Journal of Nuclear Medicine. 2005;46:658–666
  419. Yamagami T, et al. Management of pneumothorax after percutaneous CT-guided lung biopsy. Chest. 2002;121:1159–1164
  420. Yao YF, et al. Immunoscintigraphy of local recurrent rectal cancer with 99mTc- labeled anti-CEA monoclonal antibody CL58. World Journal of Gastroenterology. 2007;13(12):1841–1846
  421. Ye G, et al. A 3D EIT system for breast cancer imaging. In: 3rd IEEE International Symposium on Biomedical Imaging: Nano to Macro. 2006;p. 1092–1095
  422. Yee J, et al. Colorectal neoplasia: performance characteristics of CT colonography for detection in 300 patients. Radiology. 2001;219(3):685–692
  423. Yeung DKW, et al. Breast cancer: in vivo proton MR spectroscopy in the characterization of histopathologic subtypes and preliminary observations in axillary node metastases. Radiology. 2002;225:190–197
  424. Yu T, Huang X, Hu K, Bai J, Wang Z. Treatment of transplanted adriamycin-resistant ovarian cancers in mice by combination of adriamycin and ultrasound exposure. Ultrasonics Sonochemistry. 2004;11:287–291
  425. Yuan H, et al. Intertumoral differences in hypoxia selectivity of the PET imaging agent 64Cu(II)-diacetyl-bis(N4-methylthiosemicarbazone). Journal of Nuclear Medicine. 2006;47(6):989–998
  426. Yuan L, et al. Preliminary assessment of one-dimensional MR elastography for use in monitoring focused ultrasound therapy. Physics in Medicine and Biology. 2007;52(19):5909–5919
  427. Zagoria RJ, Hawkins AD, Clark PE, et al. Percutaneous CT-guided radiofrequency ablation of renal neoplasms: factors influencing success. AJR American Journal of Roentgenology. 2004;183:201–207
  428. Zaidi H, Alavi A. Current trends in PET and combined (PET/CT and PET/MR) systems design. PET Clinics. 2007;2:109–123
  429. Zeisel SH. Choline phospholipids: signal transduction and carcinogenesis. FASEB J. 1993;7:551–557
  430. Zhang E, Laufer J, Beard P. Backward-mode multiwavelength photoacoustic scanner using a planar Fabry–Perot polymer film ultrasound sensor for high- resolution three-dimensional imaging of biological tissues. Applied Optics. 2008;47(4):561–577
  431. Zhang HF, et al. In vivo volumetric imaging of subcutaneous microvasculature by photoacoustic microscopy. Optics Express. 2006;14(20):9317–9322
  432. Zhang X, Cheng X. Preparation and characterization of 99mTc(CO)3-BPy-RGD complex as αvβ3 integrin receptor-targeted imaging agent. Applied Radiation and Isotopes. 2007;65(1):70–78
  433. Zhang X, et al. PET imaging of cerebral astrocytoma with 13N-ammonia. Journal of Neuro-Oncology. 2006;78(2):145–151
  434. Zhang X, et al. Quantitative PET imaging of tumor integrin αvβ3 expression with18F-FRGD2. Journal of Nuclear Medicine. 2006;47(1):113–120
  435. Zhang X, Chen W. Differentiation of recurrent astrocytoma from radiation necrosis: a pilot study with 13N-NH3 PET. Journal of Neurooncology. 2007;82:305–311
  436. Zhao M, Beauregard DA, Loizou L, Davletov B, Brindle KM. Non-invasive detection of apoptosis using magnetic resonance imaging and a targeted contrast agent. Nature Medicine. 2001;7:1241–1244
  437. Zhi H, et al. Comparison of ultrasound elastography, mammography, and sonography in the diagnosis of solid breast lesions. Journal of Ultrasound in Medicine. 2007;26:807–815
  438. Zippel DB, Papa MZ. The use of MR imaging guided focused ultrasound in breast cancer patients: a preliminary phase one study and review. Breast Cancer. 2005;12:32–38
  439. Zudaire I, et al. Molecular characterization of small peripheral lung tumors based on the analysis of fine needle aspirates. Histology and Histopathology. 2008;23(1):33–40

PII: S1574-7891(08)00059-8

doi: 10.1016/j.molonc.2008.04.001

Molecular Oncology
Volume 2, Issue 2 , Pages 115-152 , August 2008

Article Tools

* Image Usage & Resolution